This trial is evaluating whether Proactive Panel Management Clinics for HFrEF will improve 1 primary outcome, 7 secondary outcomes, and 3 other outcomes in patients with Heart Failure. Measurement will happen over the course of At baseline with no comparison group.
This trial requires 300 total participants across 2 different treatment groups
This trial involves 2 different treatments. Proactive Panel Management Clinics For HFrEF is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"heart failure affects 1 in 6 adults and is the leading cause of hospitalization in Canada. By improving our knowledge about heart failure, we can better improve the outcomes for both individuals and the Canadian health care system." - Anonymous Online Contributor
"More than 1.4 million people are diagnosed with heart failure daily in the United States. This number of cases has climbed by over 15% from 1997 to 2005. Furthermore, heart failure is the leading cause of hospitalization in the United States. Patients with heart failure continue to have significant long-term health risks. Given these findings, more effective efforts are needed to improve early detection, diagnosis, and intervention of heart failure." - Anonymous Online Contributor
"heart failure results from the progressive deterioration of the heart due to its inability to maintain adequate blood flow. Understanding what causes heart failure can help patients manage the disease and reduce its impact." - Anonymous Online Contributor
"It's not obvious when the deterioration of heart failure becomes severe. The main sign is fatigue and palpitations. The physical exam will show edema and swollen ankles and elbows. The patient will feel short of breath that sounds like crackling when the heart beats. Later on, the person may see bubbles in the skin on the lower abdomen. The lower left leg may feel swollen, cold on the outside, and warm and wet on the inside. Sometimes the patient may have a sense of losing control. The heart rate will be slow and may change during the day. The person may not be able to feel their pulse from the wrist or the neck as it hurts from the heart squeezing." - Anonymous Online Contributor
"Symptoms are improved in half of the patients, especially those with HF of moderate to severe severity. HF is likely to be curable only if severe disease such as refractory shock or refractory heart failure is avoided. The risk of sudden death in those with HF may be lowered if medication is improved or if patients are monitored for cardiovascular disease." - Anonymous Online Contributor
"Patients with heart failure are treated with many medications. Some of these are commonly used in other conditions. However many patients with heart failure also suffer from other illnesses which might complicate the management of their illness and may limit their ability to access all of the potential benefits. What are the common treatments for heart failure? answer: Cardiac surgery may be beneficial to some congestive heart failure patients. However, the risks of surgery need to be balanced against the benefit of surgery." - Anonymous Online Contributor
"While many articles were published, they did not appear to review recent articles. Inclusion of recent articles could have improved our understanding of the natural course of the disease." - Anonymous Online Contributor
"Proactive panel management at an HF clinic had a negative impact on the receipt of appropriate HF treatments, particularly for patients with mild to moderate heart failure. A more proactive HF treatment approach may improve outcomes." - Anonymous Online Contributor
"The current 'ad hoc' approach to assessing and treating patients with heart failure at the panel clinic appears to be efficacious in managing cardiovascular risk in individuals with HFrEF. Patients enrolled in the PROMISE Trial were managed in a structured fashion within the proactive panel. We discuss the PROMISE Trial data and its implications for clinical practice." - Anonymous Online Contributor
"Patients with symptoms of heart failure and a relatively preserved ejection fraction were identified by the proactive care clinic and were followed over 12 months. The management recommendations of proactive care did not lead to a sustained improvement in heart failure symptoms." - Anonymous Online Contributor
"About two-thirds of patients with heart failure have some degree of exertional limitation while only about 10% are unable to perform regular activities of daily living when heart failure symptoms occur. Cardiac patients with worse symptoms or more physical disability are at greater risk for dying than patients with milder symptoms or worse disability. Therefore, heart failure is not a benign condition when the symptoms are mild, though heart failure usually progresses regardless of symptom severity or disability. Most patients with heart failure have signs of a coronary artery disease but asymptomatic disease is surprisingly common among this population. If a patient has heart failure, we should consider excluding chest pain or other potential signs of coronary disease." - Anonymous Online Contributor
"In this analysis, women with a baseline NT-proBNP >1000 pmol/liter were 3.5 to 3 fold more likely to be enrolled in a trial than men, and were also less likely to have LV reversiventure on the study completion. These differences suggest potential for bias in trial enrollment of women with systolic HF and also suggest gender differences in clinical trial recruitment." - Anonymous Online Contributor